Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales20 24720 40520 85326 35727 60829 189
Operating income (EBITDA)3 8654 8506 0756 7397 4258 356
Operating profit (EBIT)2 8723 9794 1725 8796 3806 818
Pre-Tax Profit (EBT)------
Net income2 2844 4231 4003 1064 1565 038
P/E ratio30,215,440,924,519,016,6
EPS ( $ )1,492,920,941,782,302,63
Dividend per Share ( $ )0,900,981,041,051,111,24
Yield2,00%2,18%2,71%2,40%2,53%2,84%
Reference price ( $ )45.0244.9138.4143.6443.6443.64
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt3 7822 8763 23118 31315 72412 700
Finance------
Operating income (EBITDA)3 8654 8506 0756 7397 4258 356
Leverage
(Debt/EBITDA)
0,98x0,59x0,53x2,72x2,12x1,52x
Capital Expenditure1 0771 1101 1211 3171 3051 288
Book Value Per Share (BVPS)14,3 $14,4 $13,9 $20,7 $22,1 $20,0 $
Cash Flow per Share2,41 $1,97 $2,16 $2,83 $3,50 $3,99 $
Announcement Date01/29/2015
12:45pm
01/28/2016
12:31pm
01/25/2017
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 75 410 M$ -
Entreprise Value (EV) 93 723 M$ 91 134 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 24,5x 19,0x
Capitalization / Revenue 2,86x 2,73x
EV / Revenue 3,56x 3,30x
EV / EBITDA 13,9x 12,3x
Yield (DPS / Price) 2,40% 2,53%
Price to book (Price / BVPS) 2,11x 1,98x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 22,3% 23,1%
operating Leverage (Delta EBIT / Delta Sales) 1,55x 1,80x
Net Margin (Net Profit / Revenue) 11,8% 15,1%
ROA (Net Profit / Asset) 6,28% 7,18%
ROE (Net Profit / Equities) 17,6% 13,9%
Rate of Dividend 58,9% 48,0%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   5,00% 4,73%
Cash Flow / Sales 18,6% 21,9%
Capital Intensity (Assets / Sales) 1,88x 2,10x
Financial Leverage (Net Debt / EBITDA) 2,72x 2,12x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend